Alteogen Signs $365 Million Licensing Deal for Subcutaneous Drug Delivery Platform ALT-B4
Biotechnology firm Alteogen has signed an exclusive technology-transfer agreement worth up to $365 million (approximately 521.
Search results for "technology transfer"
'2 Million Brain Cells Die Every Minute': Neurologists Call for National Strategy as South Korea Ages
"In a super-aged society, brain diseases represent a core healthcare challenge that the nation must tackle collectively, far beyond the burden placed...
Anchoring the U.S. Supply Chain: GC Green Cross Expands 30-Year Cytiva Partnership to Secure Alyglo Production
GC Green Cross has secured priority access to critical manufacturing consumables to stabilize the production of Alyglo,...
Cool vs. Dry: How to Choose Between an Air Conditioner and a Dehumidifier
As the rainy season ramps up and sweltering summer heat settles in, many households find themselves running air...
AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements
The Ministry of Health and Welfare and the Korea Health Industry Development Institute announced on the 8th that they...
From Twin Risks to Tylenol Safety: Medical Society Addresses Four Major Pregnancy Concerns
How much does risk escalate during a twin pregnancy? Is cerebral palsy strictly caused by complications during labor...
Inha University Hospital Partners with Remedi to Validate Ultra-Compact, AI-Powered X-Ray Models for Frontline Care
Inha University Hospital has signed a memorandum of understanding with Remedi, a medical technology developer...
Why Do Properly Repaired Shoulder Tendons Tear Again? The Answer Lies in Tissue 'Quality'
A man in his mid-50s, identified as Mr. A, underwent rotator cuff repair surgery to alleviate debilitating shoulder...
Hanmi Pharm Revives 'LAPSCOVERY' Momentum with $1.26B Eli Lilly Licensing Deal
Hanmi Pharmaceutical has licensed its novel drug candidate sonefpeglutide to global pharmaceutical giant Eli Lilly and...
Eli Lilly to Acquire GC Biopharma’s Curevo Vaccine in Blockbuster $1.5 Billion Deal
GC Biopharma’s U.S. affiliate, Curevo Vaccine, is set to be acquired by global pharmaceutical giant Eli Lilly in a deal...